| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | EVP of Research | Common Stock | 69.4K | $781K | $11.26 | Mar 2, 2022 | Direct |
| Aurinia Pharmaceuticals Inc. | EVP of Research | Stock Option (right to buy) | 107K | Mar 2, 2022 | Direct | ||
| Aurinia Pharmaceuticals Inc. | EVP of Research | Restricted Stock Unit | 62.4K | Mar 2, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2022 | 4 | -$58.2K | 4 | Mar 4, 2022 | EVP of Research |
| AUPH | Aurinia Pharmaceuticals Inc. | Oct 25, 2021 | 3 | -$3.56M | 4 | Oct 26, 2021 | EVP of Research |
| AUPH | Aurinia Pharmaceuticals Inc. | Sep 21, 2021 | 6 | -$702K | 4 | Sep 22, 2021 | EVP of Research |
| AUPH | Aurinia Pharmaceuticals Inc. | Sep 10, 2021 | 3 | -$687K | 4 | Sep 14, 2021 | EVP of Research |
| AUPH | Aurinia Pharmaceuticals Inc. | Sep 7, 2021 | 1 | -$91.5K | 4 | Sep 8, 2021 | EVP of Research |
| AUPH | Aurinia Pharmaceuticals Inc. | May 11, 2021 | 2 | $121K | 4 | May 11, 2021 | Ex Vice President of Research |